334 related articles for article (PubMed ID: 24037988)
41. Metformin interferes with bile acid homeostasis through AMPK-FXR crosstalk.
Lien F; Berthier A; Bouchaert E; Gheeraert C; Alexandre J; Porez G; Prawitt J; Dehondt H; Ploton M; Colin S; Lucas A; Patrice A; Pattou F; Diemer H; Van Dorsselaer A; Rachez C; Kamilic J; Groen AK; Staels B; Lefebvre P
J Clin Invest; 2014 Mar; 124(3):1037-51. PubMed ID: 24531544
[TBL] [Abstract][Full Text] [Related]
42. How sweet it is to activate FXR.
Jansen PL; Schaap FG
Hepatology; 2014 May; 59(5):1665-7. PubMed ID: 24123073
[No Abstract] [Full Text] [Related]
43. The nuclear receptor FXR regulates hepatic transport and metabolism of glutamine and glutamate.
Renga B; Mencarelli A; Cipriani S; D'Amore C; Zampella A; Monti MC; Distrutti E; Fiorucci S
Biochim Biophys Acta; 2011 Nov; 1812(11):1522-31. PubMed ID: 21757002
[TBL] [Abstract][Full Text] [Related]
44. Genetic variation in NR1H4 encoding the bile acid receptor FXR determines fasting glucose and free fatty acid levels in humans.
Heni M; Wagner R; Ketterer C; Böhm A; Linder K; Machicao F; Machann J; Schick F; Hennige AM; Stefan N; Häring HU; Fritsche A; Staiger H
J Clin Endocrinol Metab; 2013 Jul; 98(7):E1224-9. PubMed ID: 23640969
[TBL] [Abstract][Full Text] [Related]
45. The nuclear bile acid receptor FXR controls the liver derived tumor suppressor histidine-rich glycoprotein.
Deuschle U; Birkel M; Hambruch E; Hornberger M; Kinzel O; Perović-Ottstadt S; Schulz A; Hahn U; Burnet M; Kremoser C
Int J Cancer; 2015 Jun; 136(11):2693-704. PubMed ID: 25363753
[TBL] [Abstract][Full Text] [Related]
46. Dietary procyanidins selectively modulate intestinal farnesoid X receptor-regulated gene expression to alter enterohepatic bile acid recirculation: elucidation of a novel mechanism to reduce triglyceridemia.
Heidker RM; Caiozzi GC; Ricketts ML
Mol Nutr Food Res; 2016 Apr; 60(4):727-36. PubMed ID: 26718753
[TBL] [Abstract][Full Text] [Related]
47. Roles of the hexosamine biosynthetic pathway and pentose phosphate pathway in bile acid-induced cancer development.
Munemoto M; Mukaisho KI; Miyashita T; Oyama K; Haba Y; Okamoto K; Kinoshita J; Ninomiya I; Fushida S; Taniura N; Sugihara H; Fujimura T
Cancer Sci; 2019 Aug; 110(8):2408-2420. PubMed ID: 31215094
[TBL] [Abstract][Full Text] [Related]
48. Cyclosporin A induced toxicity in mouse liver slices is only slightly aggravated by Fxr-deficiency and co-occurs with upregulation of pro-inflammatory genes and downregulation of genes involved in mitochondrial functions.
Szalowska E; Pronk TE; Peijnenburg AA
BMC Genomics; 2015 Oct; 16():822. PubMed ID: 26482353
[TBL] [Abstract][Full Text] [Related]
49. Postprandial FGF19-induced phosphorylation by Src is critical for FXR function in bile acid homeostasis.
Byun S; Kim DH; Ryerson D; Kim YC; Sun H; Kong B; Yau P; Guo G; Xu HE; Kemper B; Kemper JK
Nat Commun; 2018 Jul; 9(1):2590. PubMed ID: 29968724
[TBL] [Abstract][Full Text] [Related]
50. Glucokinase expression is regulated by glucose through O-GlcNAc glycosylation.
Baldini SF; Steenackers A; Olivier-Van Stichelen S; Mir AM; Mortuaire M; Lefebvre T; Guinez C
Biochem Biophys Res Commun; 2016 Sep; 478(2):942-8. PubMed ID: 27520373
[TBL] [Abstract][Full Text] [Related]
51. Regulation of drug transporters by the farnesoid X receptor in mice.
Maeda T; Miyata M; Yotsumoto T; Kobayashi D; Nozawa T; Toyama K; Gonzalez FJ; Yamazoe Y; Tamai I
Mol Pharm; 2004; 1(4):281-9. PubMed ID: 15981587
[TBL] [Abstract][Full Text] [Related]
52. Nuclear bile acid receptor FXR in the hepatic regeneration.
Chen WD; Wang YD; Meng Z; Zhang L; Huang W
Biochim Biophys Acta; 2011 Aug; 1812(8):888-92. PubMed ID: 21167938
[TBL] [Abstract][Full Text] [Related]
53. Hepatic farnesoid X-receptor isoforms α2 and α4 differentially modulate bile salt and lipoprotein metabolism in mice.
Boesjes M; Bloks VW; Hageman J; Bos T; van Dijk TH; Havinga R; Wolters H; Jonker JW; Kuipers F; Groen AK
PLoS One; 2014; 9(12):e115028. PubMed ID: 25506828
[TBL] [Abstract][Full Text] [Related]
54. Farnesoid X Receptor Deficiency Induces Hepatic Lipid and Glucose Metabolism Disorder via Regulation of Pyruvate Dehydrogenase Kinase 4.
Deng W; Fan W; Tang T; Wan H; Zhao S; Tan Y; Oware KA; Tan J; Li J; Qu S
Oxid Med Cell Longev; 2022; 2022():3589525. PubMed ID: 35251469
[TBL] [Abstract][Full Text] [Related]
55. MECHANISMS IN ENDOCRINOLOGY: FXR signalling: a novel target in metabolic diseases.
Sonne DP
Eur J Endocrinol; 2021 May; 184(5):R193-R205. PubMed ID: 33630750
[TBL] [Abstract][Full Text] [Related]
56. Farnesoid x receptor in human metabolism and disease: the interplay between gene polymorphisms, clinical phenotypes and disease susceptibility.
Koutsounas I; Theocharis S; Delladetsima I; Patsouris E; Giaginis C
Expert Opin Drug Metab Toxicol; 2015 Apr; 11(4):523-32. PubMed ID: 25553772
[TBL] [Abstract][Full Text] [Related]
57. Role of farnesoid X receptor in cholestasis.
Yuan ZQ; Li KW
J Dig Dis; 2016 Aug; 17(8):501-509. PubMed ID: 27383832
[TBL] [Abstract][Full Text] [Related]
58. Bile acids and insulin resistance: implications for treating nonalcoholic fatty liver disease.
Wei J; Qiu DK; Ma X
J Dig Dis; 2009 May; 10(2):85-90. PubMed ID: 19426389
[TBL] [Abstract][Full Text] [Related]
59. Farnesoid X receptor-dependent and -independent pathways mediate the transcriptional control of human fibroblast growth factor 19 by vitamin A.
Jahn D; Sutor D; Dorbath D; Weiß J; Götze O; Schmitt J; Hermanns HM; Geier A
Biochim Biophys Acta; 2016 Feb; 1859(2):381-92. PubMed ID: 26723851
[TBL] [Abstract][Full Text] [Related]
60. Hepatic FXR/SHP axis modulates systemic glucose and fatty acid homeostasis in aged mice.
Kim KH; Choi S; Zhou Y; Kim EY; Lee JM; Saha PK; Anakk S; Moore DD
Hepatology; 2017 Aug; 66(2):498-509. PubMed ID: 28378930
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
